Fitch Publishes 1Q15 European Big Pharma Dashboard

April 16, 2015 8:29 AM

23 0

(The following statement was released by the rating agency) Link to Fitch Ratings' Report: European Big Pharma Dashboard 1Q15 here LONDON, April 16 (Fitch) Fitch Ratings says in its latest European Big Pharma Dashboard that the effects of recent M&A activity continues to negatively affect the ratings headroom for European pharma players as they seek to position themselves in key treatment areas and consolidate market positions.

The dashboard highlights current sector themes such as accelerating M&A activity, supported by liquid financial markets, the focus on R&D productivity and the introduction of new drugs in competitive treatment areas, as well as the emerging competition from biosimilars. The rating outlook for the se...

Read more

To category page